Moreover, Mdm2-p53 interaction has gained interest in the last years, since a better response to chemotherapy was found in patients Mdm2+/p53– in well-differentiated/dedifferentiated liposarcomas (22). This evidence concerns the gene MDM2 and liposarcoma.